Tenaya Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
TNYA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
171 Oyster Point Blvd., Suite 500, South San Francisco, CA

Insiders trading volume in the past year

Tenaya Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Column Group III Gp, Lp 10%+ Owner $34.5M +$25M +263% Mar 5, 2025
David V. Goeddel Director, 10%+ Owner $34.5M +$25M +263% May 29, 2025
Eli Casdin Director $29.4M Nov 17, 2022
Timothy Hoey Chief Scientific Officer $1.72M Mar 5, 2024
Casdin Partners Master Fund, L.P. 10%+ Owner $1.54M Aug 3, 2021
Leone D. Patterson Chief Fin. and Bus. Officer $590K Feb 23, 2024
Faraz Ali Chief Executive Officer, Director $399K -$29K -6.79% Nov 17, 2025
Whittemore Tingley Chief Medical Officer $226K -$15.4K -6.4% Nov 17, 2025
Chihiro Saito SVP, Accounting and Fin. Ops. $129K Nov 18, 2024
Tomohiro Higa SVP, Finance $125K -$7.48K -5.65% Nov 17, 2025
JeenJoo Kang Director $107K Aug 3, 2021
Catherine Stehman-Breen Director May 29, 2025
Jin Long Chen Director Jun 9, 2023
Karah Parschauer Director May 29, 2025
Jeffrey T. Walsh Director May 29, 2025
R. Sanders Williams Director May 29, 2025
Amy L. Burroughs Director May 29, 2025
Deepak Srivastava Director May 29, 2025
June Lee Director May 29, 2025

Recent Insider Transactions by Companies or Individuals for Tenaya Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.